- Home
- CDTX vs PROF Comparison
CDTX vs PROF Comparison
Compare CDTX & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- PROF
- Stock Information
- Founded
- CDTX 2012
- PROF N/A
- Country
- CDTX United States
- PROF Canada
- Employees
- CDTX N/A
- PROF N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- PROF Medical/Dental Instruments
- Sector
- CDTX Health Care
- PROF Health Care
- Exchange
- CDTX Nasdaq
- PROF Nasdaq
- Market Cap
- CDTX 207.4M
- PROF 201.2M
- IPO Year
- CDTX 2015
- PROF N/A
- Fundamental
- Price
- CDTX $21.54
- PROF $7.48
- Analyst Decision
- CDTX Strong Buy
- PROF Strong Buy
- Analyst Count
- CDTX 7
- PROF 2
- Target Price
- CDTX $32.20
- PROF $11.40
- AVG Volume (30 Days)
- CDTX 91.1K
- PROF 102.1K
- Earning Date
- CDTX 11-07-2024
- PROF 03-06-2025
- Dividend Yield
- CDTX N/A
- PROF N/A
- EPS Growth
- CDTX N/A
- PROF N/A
- EPS
- CDTX N/A
- PROF N/A
- Revenue
- CDTX $44,653,000.00
- PROF $8,984,000.00
- Revenue This Year
- CDTX N/A
- PROF $56.56
- Revenue Next Year
- CDTX N/A
- PROF $151.33
- P/E Ratio
- CDTX N/A
- PROF N/A
- Revenue Growth
- CDTX 44.48
- PROF 39.35
- 52 Week Low
- CDTX $10.00
- PROF $5.63
- 52 Week High
- CDTX $28.42
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- CDTX 48.34
- PROF 65.75
- Support Level
- CDTX $20.50
- PROF $5.63
- Resistance Level
- CDTX $24.95
- PROF $6.36
- Average True Range (ATR)
- CDTX 1.66
- PROF 0.36
- MACD
- CDTX 0.20
- PROF 0.18
- Stochastic Oscillator
- CDTX 50.36
- PROF 87.26
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.